Compare leadless and left bundle branch pacemakers for heart and valve function
Official title: Left Bundle Branch Area Pacing Versus Right Ventricular Leadless Pacing: Acute Effects on Biventricular and Tricuspid Valve Function
Run by Guy's and St Thomas' NHS Foundation Trust · NCT07534917 · Data updated 2026-11-12
This study tests whether leadless pacemakers or left bundle branch area pacing better preserve heart and tricuspid valve function in adults needing a pacemaker.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Guy's and St Thomas' NHS Foundation Trust Academic / other |
| Locations | 1 site (London) |
| Status | Recruiting |
| Started | August 18, 2026 |
| Main results expected | January 30, 2029 |
| Study ends | June 1, 2029 |
| Registry record updated | August 21, 2026 |
| Trial ID | NCT07534917 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18 years) referred for permanent pacemaker implantation with high-degree AV block and preserved ejection fraction (≥50%), at a single UK center.
✕Probably not a fit
Patients with reduced ejection fraction or significant tricuspid/right ventricular disease, or those unable to undergo MRI/CT/TOE, may not see a benefit from these approaches.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will recruit twenty adults referred for permanent pacemaker implantation and perform an acute, mechanistic comparison of temporary leadless right ventricular pacing and temporary left bundle branch area pacing during the same session before the final device is implanted. Outcomes will focus on biventricular function and tricuspid valve performance to understand the short-term cardiac effects of these newer pacing approaches compared with conventional pacing considerations. Participants have high-degree AV block or are scheduled for AV node ablation and an ejection fraction of 50% or higher. The study is conducted at Guy's and St Thomas' NHS Foundation Trust, with collaboration from King's College London, and uses standard clinical procedures for implantation.
Why it matters
Potential benefit: If successful, the trial could clarify which newer pacing strategy better protects heart function and the tricuspid valve, guiding safer choices for patients needing pacemakers.
How similar studies have gone: Limited data exist comparing leadless pacing and left bundle branch area pacing head-to-head, making this comparative acute study relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients aged ≥18 referred for a permanent pacemaker at a single centre (Guys and St. Thomas' NHS Foundation Trust, UK) with high degree AV block, including Mobitz II and complete heart block, or scheduled AV node ablation, and LVEF ≥50%. Exclusion Criteria: * LVEF \<50%, severe TR, severe RV dysfunction, clinically unstable AV block requiring temporary pacing or isoprenaline infusion, left bundle branch block, previous TV annuloplasty or replacement, aortic valve replacement, life expectancy \<1 year, end-stage renal failure, contraindication to cardiac MRI, CT or TOE, pregnancy, contraindication to anticoagulation, peripheral vascular disease precluding insertion of femoral catheters and insufficient capacity to consent to the study.
Where it's running
-
St. Thomas' Hospital
London, United Kingdom Recruiting
Study contacts
- Principal investigator: Aldo Rinaldi, MD — Guy's and St Thomas' NHS Foundation Trust
- Study coordinator: Aldo Rinaldi, MD
- Email: aldo.rinaldi@kcl.ac.uk
- Phone: +44207 188 9275
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Pulmonary Embolism Registry from Emergency Care to Long-Term Follow-Up
This registry follows adults with acute pulmonary embolism to see how care is given in the real world and what happens over time.
-
3D Echocardiography to See How CIEDs May Worsen Tricuspid Regurgitation
This study tests whether different CIEDs (leadless pacemakers, LBBaP, and conventional pacemakers) differ in causing worsening tricuspid regurgitation, using 3D heart imaging.
-
Right ventricular–arterial coupling during fluid loading in ICU patients
This study tests how the right ventricle handles fluid changes in critically ill adults to see how it affects blood flow and congestion.
-
TriClip for treating tricuspid regurgitation in Japan
This study will see if the TriClip device is safe and helps people in Japan with symptomatic severe tricuspid regurgitation when used in routine clinical care.
-
Impact of transcatheter tricuspid valve repair on kidneys, strength, and activity in older adults
This study will try catheter-based tricuspid valve repair (TEER) in older adults with severe symptomatic tricuspid regurgitation to see if kidney function, fluid overload, and physical activity improve.
-
TARGET 2.0: Cardiovalve TR replacement for tricuspid regurgitation
This study will test a percutaneously delivered Cardiovalve tricuspid replacement via the femoral vein in adults with symptomatic severe secondary tricuspid regurgitation who are high risk for open-heart surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.